TNM Staging for Renal Cell Carcinoma: Time for a New Method

被引：31

作者：

Eggener, Scott ^{[1
]}

机构：

[1] Univ Chicago, Med Ctr, Urol Sect, Chicago, IL 60637 USA

来源：

EUROPEAN UROLOGY | 2010年 / 58卷 / 04期

关键词：

PROGNOSIS; SYSTEM;

D O I：

10.1016/j.eururo.2010.08.007

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：517 / 519

页数：3

共 10 条

[1]

Breault JE, 2005, CLIN CANCER RES, V11, P557

[2] CA9 Gene: Single Nucleotide Polymorphism Predicts Metastatic Renal Cell Carcinoma Prognosis [J].

de Martino, Michela ;

Klatte, Tobias ;

Seligson, David B. ;

LaRochelle, Jeffrey ;

Shuch, Brian ;

Caliliw, Randy ;

Li, Zhenhua ;

Kabbinavar, Fairooz F. ;

Pantuckt, Allan J. ;

Belldegrun, Arie S. .

JOURNAL OF UROLOGY, 2009, 182 (02) :728-734

[3] Proposal for revision of the TNM classification system for renal cell carcinoma [J].

Ficarra, V ;

Guillè, F ;

Schips, L ;

de la Taille, A ;

Galetti, TP ;

Tostain, J ;

Cindolo, L ;

Novara, G ;

Zigeuner, R ;

Bratti, E ;

Li, GR ;

Altieri, V ;

Abbou, CC ;

Zanolla, L ;

Artibani, W ;

Patard, JJ .

CANCER, 2005, 104 (10) :2116-2123

[4] An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score [J].

Frank, I ;

Blute, ML ;

Cheville, JC ;

Lohse, CM ;

Weaver, AL ;

Zincke, H .

JOURNAL OF UROLOGY, 2002, 168 (06) :2395-2400

[5] Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial [J].

Gore, Martin E. ;

Szczylik, Cezary ;

Porta, Camillo ;

Bracarda, Sergio ;

Bjarnason, Georg A. ;

Oudard, Stephane ;

Hariharan, Subramanian ;

Lee, Se-Hoon ;

Haanen, John ;

Castellano, Daniel ;

Vrdoljak, Eduard ;

Schoffski, Patrick ;

Mainwaring, Paul ;

Nieto, Alejandra ;

Yuan, Jinyu ;

Bukowski, Ronald .

LANCET ONCOLOGY, 2009, 10 (08) :757-763

[6] Validation of the 2009 TNM Version in a Large Multi-Institutional Cohort of Patients Treated for Renal Cell Carcinoma: Are Further Improvements Needed? [J].

Novara, Giacomo ;

Ficarra, Vincenzo ;

Antonelli, Alessandro ;

Artibani, Walter ;

Bertini, Roberto ;

Carini, Marco ;

Cunico, Sergio Cosciani ;

Imbimbo, Ciro ;

Longo, Nicola ;

Martignoni, Guido ;

Martorana, Giuseppe ;

Minervini, Andrea ;

Mirone, Vincenzo ;

Montorsi, Francesco ;

Schiavina, Roberto ;

Simeone, Claudio ;

Serni, Sergio ;

Simonato, Alchiede ;

Siracusano, Salvatore ;

Volpe, Alessandro ;

Carmignani, Giorgio .

EUROPEAN UROLOGY, 2010, 58 (04) :588-595

[7] A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma [J].

Sorbellini, M ;

Kattan, MW ;

Snyder, ME ;

Reuter, V ;

Motzer, R ;

Goetzl, M ;

McKiernan, J ;

Russo, P .

JOURNAL OF UROLOGY, 2005, 173 (01) :48-51

[8]

WENG L, J PATHOL IN PRESS, DOI DOI 10.1002/PATH.2736

[9] Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer [J].

Wood, S. L. ;

Rogers, M. ;

Cairns, D. A. ;

Paul, A. ;

Thompson, D. ;

Vasudev, N. S. ;

Selby, P. J. ;

Banks, R. E. .

BRITISH JOURNAL OF CANCER, 2010, 103 (01) :101-111

[10] Improved prognostication of renal cell carcinoma using an integrated staging system [J].

Zisman, A ;

Pantuck, AJ ;

Dorey, F ;

Said, JW ;

Shvarts, O ;

Quintana, D ;

Gitlitz, BJ ;

deKernion, JB ;

Figlin, RA ;

Belldegrun, AS .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) :1649-1657

← 1 →